share_log

60 Degrees Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer DOW GEOFFREY S

SEC announcement ·  Feb 3 04:36
Summary by Futu AI
Geoffrey S. Dow, President and CEO of 60 Degrees Pharmaceuticals, completed a purchase of 25,974 shares of common stock on January 31, 2024. The transaction was carried out on the open market at a price of $0.375 per share, resulting in a total investment of $9,740.25. Following this acquisition, Dow's direct holdings in the company increased to 703,599 shares. The transaction underscores the CEO's confidence in the company and provides investors with a signal regarding the leadership's view of the stock's value.
Geoffrey S. Dow, President and CEO of 60 Degrees Pharmaceuticals, completed a purchase of 25,974 shares of common stock on January 31, 2024. The transaction was carried out on the open market at a price of $0.375 per share, resulting in a total investment of $9,740.25. Following this acquisition, Dow's direct holdings in the company increased to 703,599 shares. The transaction underscores the CEO's confidence in the company and provides investors with a signal regarding the leadership's view of the stock's value.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.